| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.02 |